This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2011 Nov;30(11):1014-5.

doi: 10.1097/INF.0b013e31823234c9.

Tolerability of rifampin monotherapy for latent tuberculosis infection in children

Irini Daskalaki, Jaehyun Byun, M Christina Dogbey, Cymara Tolbert-Warren, Barbara M Watson

PMID: 21997666
DOI: 10.1097/INF.0b013e31823234c9

Tolerability of rifampin monotherapy for latent tuberculosis infection in children

Irini Daskalaki et al. Pediatr Infect Dis J. 2011 Nov.

. 2011 Nov;30(11):1014-5.

doi: 10.1097/INF.0b013e31823234c9.

Authors

Irini Daskalaki, Jaehyun Byun, M Christina Dogbey, Cymara Tolbert-Warren, Barbara M Watson

PMID: 21997666
DOI: 10.1097/INF.0b013e31823234c9

No abstract available

PubMed Disclaimer

Similar articles

Effectiveness of 3 months of rifampicin and isoniazid chemoprophylaxis for the treatment of latent tuberculosis infection in children.
Bright-Thomas R, Nandwani S, Smith J, Morris JA, Ormerod LP. Bright-Thomas R, et al. Arch Dis Child. 2010 Aug;95(8):600-2. doi: 10.1136/adc.2010.182600. Epub 2010 Jun 7. Arch Dis Child. 2010. PMID: 20530147
Treatment of latent tuberculosis infection.
Vernon A. Vernon A. Semin Respir Crit Care Med. 2013 Feb;34(1):67-86. doi: 10.1055/s-0032-1333544. Epub 2013 Mar 4. Semin Respir Crit Care Med. 2013. PMID: 23460007 Review.
Treatment of latent tuberculosis infection.
Parekh MJ, Schluger NW. Parekh MJ, et al. Ther Adv Respir Dis. 2013 Dec;7(6):351-6. doi: 10.1177/1753465813503028. Epub 2013 Sep 20. Ther Adv Respir Dis. 2013. PMID: 24056289 Review.
Two-month regimen of isoniazid, rifampin and pirazinamid for latent tuberculosis infection.
Duarte R, Carvalho A, Correia A. Duarte R, et al. Public Health. 2012 Sep;126(9):760-2. doi: 10.1016/j.puhe.2012.04.008. Epub 2012 May 24. Public Health. 2012. PMID: 22633080 No abstract available.
Treatment of latent TB: first do no harm.
Smith BM, Menzies D. Smith BM, et al. Expert Rev Anti Infect Ther. 2011 May;9(5):491-3. doi: 10.1586/eri.11.35. Expert Rev Anti Infect Ther. 2011. PMID: 21609258 No abstract available.

See all similar articles

Cited by

A scoping review of paediatric latent tuberculosis infection care cascades: initial steps are lacking.
Campbell JI, Sandora TJ, Haberer JE. Campbell JI, et al. BMJ Glob Health. 2021 May;6(5):e004836. doi: 10.1136/bmjgh-2020-004836. BMJ Glob Health. 2021. PMID: 34016576 Free PMC article.
Old and new approaches to diagnosing and treating latent tuberculosis in children in low-incidence countries.
Cruz AT, Starke JR, Lobato MN. Cruz AT, et al. Curr Opin Pediatr. 2014 Feb;26(1):106-13. doi: 10.1097/MOP.0000000000000049. Curr Opin Pediatr. 2014. PMID: 24299911 Free PMC article. Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer